Tang Lab
Biophotonic Imaging Laboratory
University of Oklahoma
University of Oklahoma

3/2026 - Tang Lab presented four posters at the 2026 Annual Cancer Research Symposium

Mar 13, 2026

On March 13, 2026, Tang Lab presented four posters at the 2026 Annual Cancer Research Symposium held at OU Health in Oklahoma City, Oklahoma. The presentations highlighted our ongoing work in optical coherence tomography for percutaneous nephrostomy guidance, liver transplantation assessment, and ovarian cancer therapy evaluation.

  1. "Evaluation of Repurposing Anti-Parasite Drugs for Ovarian Cancer from Cell to Animal Level Using Optical Coherence Tomography."
  2. "Multimodal, Forward-Viewing Optical Coherence Tomography (OCT) Endoscope Integrated with Optical Coherence Elastography (OCE) for Percutaneous Nephrostomy Guidance."
  3. "Optical Coherence Tomography Evaluation of Mebendazole Therapeutic Efficacy in Ovarian Cancer Xenografts."
  4. "Optical Coherence Tomography Detects Biliary Microstructural Alterations for Evaluating Bile Duct Viability in Liver Transplantation."
A Tang Lab presenter discusses a poster on bile duct viability in liver transplantation during the 2026 Annual Cancer Research Symposium.
Poster discussion on OCT-based evaluation of bile duct viability in liver transplantation during the symposium session.

A Tang Lab presenter explains the forward-viewing OCT and OCE endoscope poster to an attendee.
Discussion of the multimodal forward-viewing OCT and OCE endoscope developed for percutaneous nephrostomy guidance.

A Tang Lab member stands beside a poster on OCT-based evaluation of ovarian cancer therapy.
Poster presentation featuring OCT-based quantitative evaluation of therapy response in ovarian cancer models.

A Tang Lab member presents an ovarian cancer therapy poster at the 2026 Annual Cancer Research Symposium.
Another view from the poster session highlighting Tang Lab's ovarian cancer imaging and therapy evaluation research.

Back to News